Satoshi Imaizumi

Dr. Satoshi Imaizumi

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Circulation Journal
Verified
Journal Article
Open access
PDF file
KTKohei Takata
Kohei Takata
SISatoshi Imaizumi
Satoshi Imaizumi
EKEmi Kawachi
Emi Kawachi
YSYasunori Suematsu
Yasunori Suematsu
TSTomohiko Shimizu
Tomohiko Shimizu
KSKeijirio Saku
Keijirio Saku
Background:Smoking cessation reduces the risk of cardiovascular disease (CVD) and improves clinical outcomes in public health. We studied the effect of smoking cessation on high-density lipoprotein (HDL) functionality.Methods and Results:We randomly treated 32 smokers with varenicline or a transdermal nicotine patch as part of a 12-week smoking cessation program (The VN-SEESAW Study). The plasma lipid profiles, plasma and HDL malondialdehyde (MDA) levels, HDL subfractions as analyzed by capillary isotachophoresis, cholesterol efflux capacity, and antiinflammatory activity of HDL were measured before and after the anti-smoking intervention. After smoking cessation, HDL-C, apoA-I levels and HDL subfractions were not significantly different from the respective baseline values. However, cholesterol efflux capacity and the HDL inflammatory index (HII) were significantly improved after smoking cessation. The changes in both parameters (%∆ cholesterol efflux capacity and ∆HII) were also significantly improved in the successful smoking cessation group compared with the unsuccessful group. The changes in cholesterol efflux capacity and HII also correlated with those in end-expiratory CO concentration and MDA in HDL, respectively.Conclusions:Our findings indicate that smoking cessation leads to improved HDL functionality, increased cholesterol efflux capacity and decreased HII, without changing HDL-C or apoA-I levels or HDL subfractions. This may be one of the mechanisms by which smoking cessation improves the risk of CVD. (Circ J 2014; 78: 2955–2962)

1 August 2016 in Cardiovascular Diagnosis and Therapy
Verified
Journal Article
Closed access
PDF file
KTKohei Takata
Kohei Takata
SISatoshi Imaizumi
Satoshi Imaizumi
BZBo Zhang
Bo Zhang
SMShin-Ichiro Miura
Shin-Ichiro Miura
KSKeijiro Saku
Keijiro Saku
The prevalence of atherosclerotic cardiovascular diseases (ASCVDs) is increasing globally and they have become the leading cause of death in most countries. Numerous experimental and clinical studies have been conducted to identify major risk factors and effective control strategies for ASCVDs. The development of imaging modalities with the ability to determine the plaque composition enables us to further identify high-risk plaque and evaluate the effectiveness of different treatment strategies. While intensive lipid-lowering by statins can stabilize or even regress plaque by various mechanisms, such as the reduction of lipid accumulation in a necrotic lipid core, the reduction of inflammation, and improvement of endothelial function, there are still considerable residual risks that need to be understood. We reviewed important findings regarding plaque vulnerability and some encouraging emerging approaches for plaque stabilization.

1 March 2016 in International Journal of Cardiology
Verified
Journal Article
Closed access
KTKohei Takata
Kohei Takata
SISatoshi Imaizumi
Satoshi Imaizumi
EKEmi Kawachi
Emi Kawachi
EYEiji Yahiro
Eiji Yahiro
YSYasunori Suematsu
Yasunori Suematsu
KSKeijiro Saku
Keijiro Saku

25 November 2021 in Sustainability
Verified
Journal Article
Open access
PDF file
SMShin-ichiro Miura
Shin-ichiro Miura
DNDaisuke Nose
Daisuke Nose
KKKatsutoshi Kanamori
Katsutoshi Kanamori
SISatoshi Imaizumi
Satoshi Imaizumi
HSHideo Shimura
Hideo Shimura
KSKeijirio Saku
Keijirio Saku
The medical working environment in small and medium-sized hospitals is becoming more intense, and the coronavirus epidemic has threatened the hospital management base in Japan. To establish the future sustainable management of hospitals using internal and external environmental data, a cross SWOT (Strengths, Weaknesses, Opportunities and Threats) analysis may be a very useful tool. A cross SWOT analysis considers four strategies: an offensive strategy (SO), a confrontation strategy (ST), a strengthening strategy (WO) and a defense strategy (WT). Here, using a cross SWOT analysis, we consider the future direction of an older medium-sized hospital as one case. The most important issue is to balance the interests of hospital management with those of patients. As a sustainable strategy for this purpose, we forecast the medical situation in the Fukuoka-Itoshima Medical Area, including the Fukuoka-Nishi area in Japan, and the future profitability of a medium-sized hospital for the next 30 to 40 years. Based on the data, we used a cross SWOT analysis to analyze the current situation at the hospital and formulated measures to realize innovations at the hospital that respond to the needs of patients and the community. According to this analysis, for the future sustainable management as a hospital, we should plan to become a more community-based by increasing our capacity to treat elderly inpatients and outpatients with cardiovascular, gastrointestinal and respiratory diseases and to increase the number of beds dedicated to community comprehensive care. Furthermore, through close cooperation with highly specialized and advanced medical institutions, we need to create a new type of regional medical cooperation that can bridge the gap between regional medical care and advanced medical care. We also need to open a cardiovascular-rhythm center and a gastrointestinal endoscopy center and establish an appropriate working system for staff. The future direction for this older hospital should include plans for relocation and reconstruction, considering the balance between expected changes in income and expenses. In conclusion, we performed a cross SWOT analysis with SO, ST, WO and WT. The analysis can be a very useful tool for planning the future direction of hospitals using internal and external environmental data, and our older hospital should eventually be able to achieve sustainable developmental innovations by rebuilding while working on various strategies.

1 November 2014 in IJC Metabolic & Endocrine
Verified
Journal Article
Open access
SMShin-ichiro Miura
Shin-ichiro Miura
YSYasunori Suematsu
Yasunori Suematsu
YMYoshino Matsuo
Yoshino Matsuo
SISatoshi Imaizumi
Satoshi Imaizumi
EYEiji Yahiro
Eiji Yahiro
KSKeijiro Saku
Keijiro Saku

1 September 2002 in Journal of Orthopaedic Science
Verified
Journal Article
Closed access
PDF file
SISatoshi Imaizumi
Satoshi Imaizumi
TMTetsuro Morita
Tetsuro Morita
HKHiroto Kobayashi
Hiroto Kobayashi
TITakui Ito
Takui Ito
YHYasuharu Hirata
Yasuharu Hirata